F. Porreca

1.2k total citations
19 papers, 974 citations indexed

About

F. Porreca is a scholar working on Cellular and Molecular Neuroscience, Physiology and Molecular Biology. According to data from OpenAlex, F. Porreca has authored 19 papers receiving a total of 974 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Cellular and Molecular Neuroscience, 11 papers in Physiology and 10 papers in Molecular Biology. Recurrent topics in F. Porreca's work include Neuropeptides and Animal Physiology (16 papers), Pain Mechanisms and Treatments (11 papers) and Receptor Mechanisms and Signaling (5 papers). F. Porreca is often cited by papers focused on Neuropeptides and Animal Physiology (16 papers), Pain Mechanisms and Treatments (11 papers) and Receptor Mechanisms and Signaling (5 papers). F. Porreca collaborates with scholars based in United States and France. F. Porreca's co-authors include Peter J. Horan, Henry I. Yamamura, J. Andrew Taylor, Victor J. Hruby, Julius S. Heyman, John R. Omnaas, Jeffry L. Vaught, Henry I. Mosberg, Russell J. Sheldon and Edward J. Bilsky and has published in prestigious journals such as Nature Communications, Journal of Neuroscience and Brain Research.

In The Last Decade

F. Porreca

18 papers receiving 950 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F. Porreca United States 14 743 569 530 79 64 19 974
Frank Porreca United States 16 614 0.8× 526 0.9× 430 0.8× 82 1.0× 90 1.4× 17 924
C. Dykstra United States 8 483 0.7× 727 1.3× 234 0.4× 104 1.3× 47 0.7× 8 823
Margit Szikszay Hungary 16 460 0.6× 391 0.7× 348 0.7× 78 1.0× 102 1.6× 39 811
Yuuichi Hori Japan 15 410 0.6× 377 0.7× 282 0.5× 55 0.7× 60 0.9× 28 816
Katharyn Spiegel United States 10 309 0.4× 354 0.6× 302 0.6× 110 1.4× 46 0.7× 13 729
Philip J. Monroe United States 15 370 0.5× 262 0.5× 266 0.5× 97 1.2× 80 1.3× 23 656
Wojciech Margas United States 14 657 0.9× 311 0.5× 552 1.0× 81 1.0× 43 0.7× 33 1.0k
Kai Shen United States 12 653 0.9× 415 0.7× 518 1.0× 34 0.4× 45 0.7× 21 872
H. Oanh Nguyen United States 8 459 0.6× 369 0.6× 292 0.6× 49 0.6× 68 1.1× 8 659
C. F. C. SMITH Netherlands 9 582 0.8× 258 0.5× 606 1.1× 49 0.6× 42 0.7× 18 909

Countries citing papers authored by F. Porreca

Since Specialization
Citations

This map shows the geographic impact of F. Porreca's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Porreca with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Porreca more than expected).

Fields of papers citing papers by F. Porreca

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Porreca. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Porreca. The network helps show where F. Porreca may publish in the future.

Co-authorship network of co-authors of F. Porreca

This figure shows the co-authorship network connecting the top 25 collaborators of F. Porreca. A scholar is included among the top collaborators of F. Porreca based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Porreca. F. Porreca is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Martin, Laurent, Harrison J. Stratton, Kimberly Gómez, et al.. (2025). Anti-CV2/CRMP5 autoantibodies as drivers of sensory neuron excitability and pain in rats. Nature Communications. 16(1). 7311–7311.
2.
Largent‐Milnes, Tally M., Denise Giuvelis, Takashi Yamamoto, et al.. (2013). Building a Better Analgesic: Multifunctional Compounds that Address Injury-Induced Pathology to Enhance Analgesic Efficacy while Eliminating Unwanted Side Effects. Journal of Pharmacology and Experimental Therapeutics. 347(1). 7–19. 27 indexed citations
3.
Ibrahim, Mohab, Nicola J. Stagg, Heriberto P. Mata, et al.. (2006). CB2 cannabinoid receptor mediation of antinociception. Acute Pain. 8(3). 142–142. 2 indexed citations
4.
Gardell, Luis R., et al.. (2003). Enhanced Evoked Excitatory Transmitter Release in Experimental Neuropathy Requires Descending Facilitation. Journal of Neuroscience. 23(23). 8370–8379. 108 indexed citations
5.
Porreca, F., et al.. (1998). Spinal opioid mu receptor expression in lumbar spinal cord of rats following nerve injury. Brain Research. 795(1-2). 197–203. 107 indexed citations
6.
Lai, Josephine, Maureen Riedl, Laura S. Stone, et al.. (1996). Immunofluorescence analysis of antisense oligodeoxynucleotide-mediated ‘knock-down’ of the mouse δ opioid receptor in vitro and in vivo. Neuroscience Letters. 213(3). 205–208. 17 indexed citations
7.
Bilsky, Edward J., Charles E. Inturrisi, Wolfgang Sadée, Victor J. Hruby, & F. Porreca. (1996). Competitive and non-competitive NMDA antagonists block the development of antinociceptive tolerance to morphine, but not to selective μ or δ opioid agonists in mice. Pain. 68(2). 229–237. 102 indexed citations
8.
Horan, Peter J., B R de Costa, Kenner C. Rice, et al.. (1993). Differential antagonism of bremazocine- and U69,593-induced antinociception by quadazocine: further functional evidence of opioid kappa receptor multiplicity in the mouse.. Journal of Pharmacology and Experimental Therapeutics. 266(2). 926–933. 26 indexed citations
9.
Horan, Peter J., J. Andrew Taylor, Henry I. Yamamura, & F. Porreca. (1992). Extremely long-lasting antagonistic actions of nor-binaltorphimine (nor-BNI) in the mouse tail-flick test.. Journal of Pharmacology and Experimental Therapeutics. 260(3). 1237–1243. 196 indexed citations
10.
Horan, Peter J., Ronald J. Tallarida, Ronald C. Haaseth, et al.. (1992). Antinociceptive interactions of opioid delta receptor agonists with morphine in mice: Supra- and sub-additivity. Life Sciences. 50(20). 1535–1541. 55 indexed citations
11.
Raffa, Robert B., Rebecca P. Martinez, & F. Porreca. (1992). Lack of antinociceptive efficacy of intracerebroventricular [D-Ala2,Glu4]deltorphin, but not [D-Pen2,D-Pen5]enkephalin, in the μ-opioid receptor deficient CXBX mouse. European Journal of Pharmacology. 216(3). 453–456. 20 indexed citations
12.
Weber, Steven, et al.. (1992). Whole body and brain distribution of [3H]cyclic [D-Pen2,D-Pen5] enkephalin after intraperitoneal, intravenous, oral and subcutaneous administration.. Journal of Pharmacology and Experimental Therapeutics. 263(3). 1308–1316. 62 indexed citations
13.
Sheldon, Russell J., L. Nunan, & F. Porreca. (1989). Differential modulation by [D-Pen2, D-Pen5]enkephalin and dynorphin A-(1-17) of the inhibitory bladder motility effects of selected mu agonists in vivo.. Journal of Pharmacology and Experimental Therapeutics. 249(2). 462–469. 36 indexed citations
14.
Porreca, F., Julius S. Heyman, Henry I. Mosberg, John R. Omnaas, & Jeffry L. Vaught. (1988). Role of mu and delta receptors in the supraspinal and spinal analgesic effects of [D-Pen2, D-Pen5] enkephalin in the mouse. Pain. 33(2). 267–267. 144 indexed citations
15.
Porreca, F., Julius S. Heyman, Henry I. Mosberg, John R. Omnaas, & Jeffry L. Vaught. (1987). Role of mu and delta receptors in the supraspinal and spinal analgesic effects of [D-Pen2, D-Pen5]enkephalin in the mouse.. Journal of Pharmacology and Experimental Therapeutics. 241(2). 393–400. 30 indexed citations
16.
Sheldon, Russell J., L. Nunan, & F. Porreca. (1987). Mu antagonist properties of kappa agonists in a model of rat urinary bladder motility in vivo.. Journal of Pharmacology and Experimental Therapeutics. 243(1). 234–240. 37 indexed citations
17.
Davis, Thomas P., et al.. (1987). The proenkephalin A fragment peptide E is metabolized centrally to a novel peptide with opioid activity.. PubMed. 30. 321–5. 2 indexed citations
18.
Davis, Thomas P., F. Porreca, & A. Dray. (1984). The pro-enkephalin A derivative, peptide E, is centrally processed to active fragments.. PubMed. 27. 577–81. 2 indexed citations
19.
Porreca, F., A. Cowan, & Thomas F. Burks. (1983). Differential efficacies of proposed kappa agonists on gastrointestinal transit in mice. Federation Proceedings. 42(3). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Frank Porreca Breakdown of academic impact, for papers by C. Dykstra Breakdown of academic impact, for papers by Margit Szikszay Breakdown of academic impact, for papers by Yuuichi Hori Breakdown of academic impact, for papers by Katharyn Spiegel Breakdown of academic impact, for papers by Philip J. Monroe Breakdown of academic impact, for papers by Wojciech Margas Breakdown of academic impact, for papers by Kai Shen Breakdown of academic impact, for papers by H. Oanh Nguyen Breakdown of academic impact, for papers by C. F. C. SMITH
Rankless by CCL
2026